Br J Urol. 1989 May;63(5):531-4.

Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer.

Source

Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Oslo.

Abstract

Of 781 patients with germ cell cancer, 14 developed a second (subsequent) testicular cancer during follow-up. The incidence was not related to the treatment of the first germ cell cancer. In particular, adequate cisplatin-based chemotherapy did not reduce the risk of developing a second tumour. Screening programmes in patients with previous germ cell tumours should include all patients, irrespective of prior treatment.

PMID:: 2543475; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Cisplatin

LinkOut - more resources

Medical

Molecular Biology Databases

CIS-DIAMINEDICHLOROPLATINUM - HSDB

Supplemental Content

Save items

Related citations in PubMed

Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients. [Eur J Cancer. 1997]
Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients.
Wanderås EH, Fosså SD, Tretli S. Eur J Cancer. 1997 Feb; 33(2):253-62.
Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ. [APMIS. 2003]
Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.
Oliver RT, Ong J, Berney D, Nargund V, Badenoch D, Shamash J. APMIS. 2003 Jan; 111(1):86-91; discussion 91-2.
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group. [Br J Cancer. 2002]
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
Kollmannsberger C, Rick O, Klaproth H, Kubin T, Sayer HG, Hentrich M, Welslau M, Mayer F, Kuczyk M, Spott C, et al. Br J Cancer. 2002 Sep 23; 87(7):729-32.
Review Pharmacotherapy of relapsed metastatic testicular cancer. [Expert Opin Pharmacother. 2008]
Review Pharmacotherapy of relapsed metastatic testicular cancer.
Kollmannsberger C, Honecker F, Bokemeyer C. Expert Opin Pharmacother. 2008 Sep; 9(13):2259-72.
Review [Late toxicity after chemotherapy of malignant testicular tumors]. [Urologe A. 1998]
Review [Late toxicity after chemotherapy of malignant testicular tumors].
Jakob A, Kollmannsberger C, Kanz L, Bokemeyer C. Urologe A. 1998 Nov; 37(6):635-47.

See reviews... See all...

Cited by 3 PubMed Central articles

Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience. [Br J Cancer. 1996]
Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.
Gerl A, Clemm C, Schmeller N, Hartenstein R, Lamerz R, Wilmanns W. Br J Cancer. 1996 Oct; 74(8):1280-5.
Inheritance and testicular cancer. [Br J Cancer. 1995]
Inheritance and testicular cancer.
Nicholson PW, Harland SJ. Br J Cancer. 1995 Feb; 71(2):421-6.
Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia. [Br J Cancer. 1992]
Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia.
Klys HS, Whillis D, Howard G, Harrison DJ. Br J Cancer. 1992 Sep; 66(3):589-93.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cisplatin-based chemotherapy does not eliminate the risk of a second testicular ...
Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer.
Br J Urol. 1989 May ;63(5):531-4.

PubMed
The phosphoglycerate mutases.
The phosphoglycerate mutases.
Adv Enzymol Relat Areas Mol Biol. 1989 ;62:227-313.

PubMed
Purification of replication protein C, a cellular protein involved in the initia...
Purification of replication protein C, a cellular protein involved in the initial stages of simian virus 40 DNA replication in vitro.
Proc Natl Acad Sci U S A. 1989 May ;86(10):3584-8.

PubMed
Lyme neuroborreliosis: central nervous system manifestations.
Lyme neuroborreliosis: central nervous system manifestations.
Neurology. 1989 Jun ;39(6):753-9.

PubMed
Benzodiazepine and beta-carboline interactions with GABAA receptor-gated chlorid...
Benzodiazepine and beta-carboline interactions with GABAA receptor-gated chloride channels in mammalian cultured spinal cord neurons.
J Pharmacol Exp Ther. 1989 May ;249(2):418-23.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: